PAPER Schenker RA, Marinescu I, Stovicek PO, Lukács E, Pauna-Cristian L, Nica-Badea D, Ciurea ME
SEARCH RESULTS
300519 RESULTS
PAPER Spinelli EG, Ghirelli A, Riva N, Canu E, Castelnovo V, Domi T, Pozzi L, Carrera P, Silani V, Chiò A, Filippi M, Agosta F
Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian.
Front Neurol. 2022;13:931006. Epub 2022 Jul 15 PubMed.PAPER Torres G, Mourad M, Leheste JR
Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136--> His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
Cureus. 2022 Jun;14(6):e26247. Epub 2022 Jun 23 PubMed.PAPER Niu Q, Liu W, Wang F, Tian L, Dong Y
Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
Front Psychiatry. 2022;13:930121. Epub 2022 Jul 14 PubMed.PAPER Chen C, Wang Y, Rao J, Tang W, Wu W, Li Y, Xu G, Zhong W
Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136--> His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
Front Psychiatry. 2022;13:917766. Epub 2022 Jul 14 PubMed.PAPER Shcherbakova K, Schwarz A, Apryatin S, Karpenko M, Trofimov A
Case Report: Lipoprotein Glomerulopathy Complicated by Atypical Hemolytic Uremic Syndrome.
Front Nutr. 2022;9:934497. Epub 2022 Jul 15 PubMed.PAPER Zhou S, Wang Q, Zhang J, Wang Q, Hou F, Han X, Hu S, Shen G, Zhang Y
A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Front Public Health. 2022;10:939150. Epub 2022 Jul 13 PubMed.PAPER Zhang YM, Cheng YZ, Wang YT, Wei RM, Ge YJ, Kong XY, Li XY
Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand.
Front Behav Neurosci. 2022;16:943900. Epub 2022 Jul 13 PubMed.PAPER Roach JC, Hara J, Fridman D, Lovejoy JC, Jade K, Heim L, Romansik R, Swietlikowski A, Phillips S, Rapozo MK, Shay MA, Fischer D, Funk C, Dill L, Brant-Zawadzki M, Hood L, Shankle WR
Structure of the minimal interface between ApoE and LRP.
Alzheimers Dement (N Y). 2022;8(1):e12318. Epub 2022 Jul 26 PubMed.PAPER Mast BT, Ertle EM, Kolanowski A, Mountain G, Moniz-Cook E, Halek M
A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Alzheimers Dement (N Y). 2022;8(1):e12316. Epub 2022 Jul 26 PubMed.PAPER Shi J, Yin Q, Zhang L, Wu Y, Yi P, Guo M, Li H, Yuan L, Wang Z, Zhuang P, Zhang Y
Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: a case report.
Front Pharmacol. 2022;13:898360. Epub 2022 Jul 15 PubMed.PAPER Shan J, Tian H, Zhou C, Wang H, Ma X, Li R, Yu H, Chen G, Zhu J, Cai Z, Lin C, Cheng L, Xu Y, Liu S, Zhang C, Luo Q, Zhang Y, Jin S, Liu C, Zhang Q, Lv L, Yang L, Chen J, Li Q, Liu W, Yue W, Song X, Zhuo C, China; MODMD Group of China (CMODG)
Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
Front Pharmacol. 2022;13:904908. Epub 2022 Jul 13 PubMed.PAPER Polyakova M, Mueller K, Arelin K, Lampe L, Rodriguez FS, Luck T, Kratzsch J, Hoffmann KT, Riedel-Heller S, Villringer A, Schoenknecht P, Schroeter ML
Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
Front Cell Neurosci. 2022;16:788150. Epub 2022 Jul 14 PubMed.PAPER Ahmed T, Ko J
Identification of a new apolipoprotein E variant (E2 Arg142--> Leu) in type III hyperlipidemia.
Front Mol Neurosci. 2022;15:979511. Epub 2022 Jul 13 PubMed.PAPER Felderhoff-Müser U, Hüning B
Identification of a new apolipoprotein E variant (E2 Arg142--> Leu) in type III hyperlipidemia.
Monatsschr Kinderheilkd. 2022;170(8):688-703. Epub 2022 Jul 1 PubMed.Current Filters
No filters selected